Wolfgang Miesbach: Exploring the Role of Micronutrients in Healthy Longevity
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“New RCT evidence says: possibly yes.
A large-scale randomized controlled trial — the COSMOS study — offers evidence that daily multivitamin–multimineral supplementation may modestly decelerate epigenetic aging in older adults:
Among 958 participants (mean age 70 years), 2 years of daily Centrum Silver — a standard multivitamin — significantly slowed the rise of well-validated epigenetic aging clocks (biological ‘speedometers’ derived from DNA methylation patterns that predict mortality risk).
Importantly, vitamins improved aging biomarkers: telomere length, and markers of cellular senescence, immune activation, and mitochondrial dysfunction.
The benefit was strongest in those with already accelerated biological aging at baseline — suggesting the greatest geroprotective effect in those who may need it most.
Interestingly, cocoa flavanol extract (500 mg/day) showed no significant effect on any of the five epigenetic clocks tested.
However, whether improvements in epigenetic clocks translate into meaningful clinical outcomes still needs to be confirmed in longer follow-up studies.
The authors propose that correcting subclinical micronutrient deficiencies may be the key driver — with likely even greater effects in less well-nourished populations.”
Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series